Using magnesium injections to avoid steroids during pain management
Magnesium Injection Ensures Analgesia and Steroid Avoidance During Vaccination, Viremia or Immunocompromise
This study tests whether magnesium injections can help people with chronic pain manage their symptoms and sleep better without the side effects of steroids.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 20 Years to 99 Years |
| Sex | All |
| Sponsor | Salem Anaesthesia Pain Clinic Academic / other |
| Locations | 1 site (Surrey, British Columbia) |
| Trial ID | NCT05862454 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the use of magnesium injections as an alternative to steroid injections for managing chronic pain. It focuses on patients who have previously undergone interventional injection therapy and collects data on pain and sleep quality post-injection. Pain is assessed using a numeric rating scale, while sleep quality is measured with a Likert scale. The study aims to determine if magnesium can effectively reduce pain and improve sleep without the immunosuppressive side effects associated with steroids.
Who should consider this trial
Good fit: Ideal candidates are adult chronic pain patients who have previously received interventional injection therapy and can comply with treatment and diary requirements.
Not a fit: Patients with organ insufficiency, cognitive disorders, or those who have had adverse reactions to magnesium may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a safer pain management option for patients by reducing the risk of infections associated with steroid use.
How similar studies have performed: While the use of magnesium in this context is less common, similar studies exploring alternative pain management strategies have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult chronic pain patients * previous interventional injection therapy * consent for interventional injection therapy * good treatment compliance * regular sleep diary * regular pain diary * informed consent for diary review * consent for clinical record quality assurance review Exclusion Criteria: * organ insufficiency * cognitive disorder * inability to provide consent * major neuropsychiatric disorder * unreliable diary * poor treatment compliance * previous adverse/allergic reactions to magnesium
Where this trial is running
Surrey, British Columbia
- Salem Anaesthesia Pain Clinic — Surrey, British Columbia, Canada (Recruiting)
Study contacts
- Principal investigator: Olu Bamgbade, MD,FRCPC — Salem Anaesthesia Pain Clinic
- Study coordinator: Olu Bamgbade, MD,FRCPC
- Email: salem.painclinic@gmail.com
- Phone: 17786286600
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.